American skeptics fuel ongoing pharma 'trust deficit' despite pandemic gains, research finds

Can the pharma industry to build long-term trust with consumers post-pandemic? (Getty Images)
Despite the pandemic and the promise of a relationship reset, half of Americans still don’t trust pharma companies. That’s according to Deloitte focus group studies in the U.S., India, South Africa and the U.K.
While 80% of those surveyed in the other three countries said they trusted or were neutral toward pharma, Americans remain skeptical.
It’s not all bad news, though. Deloitte found that the pandemic has moved the needle somewhat—and in broader reputation polls even more. Plus, there is reason to hope for more, the firm found.

Related Keywords

South Africa , United States , India , Americans , Hanno Ronte , Deloitte , Monitor Deloitte , ஒன்றுபட்டது மாநிலங்களில் , இந்தியா , அமெரிக்கர்கள் , டெலோய்ட்டே , மானிட்டர் டெலோய்ட்டே ,